This is a service of EIN News a digital news provider
Thursday November 26, 2009
Healthcare Industry Today
Sign up for a free trial
Register Now
Member center Log In
Amitiza News is an EIN News Service for health professionals. Constantly updated news and information about health.
FORMATS: RSS | EMAIL

Latest Amitiza News

Sort by: relevance (24 hours) relevance date
  • BioWatch: HGS seeks OK for hepatitis C treatment 26 Nov 2009 10:12 GMT
    ... federal regulatory approval to market its new treatment for hepatitis C. The Rockville biotech is ... could total $507.5 million, HGS said. The drug is made by genetically fusing human albumin, ... received Swiss regulatory approval to market its Amitiza gel capsules for treating chronic idiopathic constipation. ...

  • Sucampo Receives Marketing Authorization for Amitiza in Switzerland for Treatment of Chronic Idiopathic Constipation 19 Nov 2009 21:32 GMT
    ... Sucampo Receives Marketing Authorization for Amitiza in Switzerland for Treatment of Chronic Idiopathic Constipation BETHESDA, Md. - ... already approved by the U.S. Food and Drug Administration (FDA) for the long-term treatment of ...

  • Sucampo Receives Marketing Authorization For Amitiza(R) In Switzerland For Treatment Of Chronic Idiopathic Constipation 21 Nov 2009 05:51 GMT
    ... microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic (CIC). This ... first European regulatory approval for Sucampo and Amitiza is the first prescription medicine to be ... already approved by the U.S. Food and Drug Administration (FDA) for the long-term treatment of ...

  • Swissmedic grants marketing authorization for Amitiza 20 Nov 2009 06:37 GMT
    ... Products, has granted a marketing authorization for Amitiza (lubiprostone) 24 microgram (mcg) gel capsules for ... microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC). ... already approved by the U.S. Food and Drug Administration (FDA) for the long-term treatment of ...

  • Sucampo Receives Marketing Authorization for Amitiza® in Switzerland for Treatment of Chronic Idiopathic Constipation 19 Nov 2009 21:34 GMT
    ... ...

  • Sucampo receives marketing author... 20 Nov 2009 13:10 GMT
    ... microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC). ... first European regulatory approval for Sucampo and Amitiza is the first prescription medicine to be ... already approved by the U.S. Food and Drug Administration (FDA) for the long-term treatment of ...

  • Sucampo announces Lubiprostone da... 26 Nov 2009 13:51 GMT
    ... safety and efficacy of lubiprostone as a treatment for chronic idiopathic constipation in adults, regardless ... has granted a marketing authorization for lubiprostone (Amitiza) 24 mcg gel capsule BID for the ... adult women. Sucampo also is developing the drug for additional gastrointestinal disorders with large potential ...

  • Sucampo Announces Lubiprostone Data Presented at GASTRO 2009 UEGF/WCOG 25 Nov 2009 13:50 GMT
    ... safety and efficacy of lubiprostone as a treatment for chronic idiopathic constipation in adults, regardless ... has granted a marketing authorization for lubiprostone (Amitiza) 24 mcg gel capsule BID for the ... adult women. Sucampo also is developing the drug for additional gastrointestinal disorders with large potential ...

  • Sucampo Announces Lubiprostone Data Presented at GASTRO 2009 UEGF/WCOG (BIZ) 25 Nov 2009 13:54 GMT
    ... safety and efficacy of lubiprostone as a treatment for chronic idiopathic constipation in adults, regardless ... has granted a marketing authorization for lubiprostone (Amitiza) 24 mcg gel capsule BID for the ... adult women. Sucampo also is developing the drug for additional gastrointestinal disorders with large potential ...

  • U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX 24 Nov 2009 09:58 GMT
    ... demonstrated dramatic effects in the prevention and treatment of severely ... Mothers receiving highly active ... today announced that the U.S. Food and Drug Administration (... Most children who suffer from ... U.S. Food and Drug Administration today approved Amitiza (lubiprostone) for the treatment of Irr... When ...

  • Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting 25 Nov 2009 15:16 GMT
    ... Sucampo Pharma Americas, Inc., subsidiaries of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), today presented additional clinical data ... today presented additional clinical data for lubiprostone (Amitiza ) at GASTRO 2009 UEGF/WCOG, the joint ... safety and efficacy of lubiprostone as a treatment for chronic idiopathic constipation in adults, regardless ...

  • Lubiprostone Approved in Switzerland for Chronic Idiopathic Constipation 20 Nov 2009 01:35 GMT
    ... has granted a marketing authorization for lubiprostone (Amitiza) 24 mcg gel capsules for the long-term treatment of patients with chronic idiopathic constipation. The ... United States. The pooled data from these trials showed that 60% of patients treated with ...

  • European Stocks May Rebound 20 Nov 2009 06:53 GMT
    ... Sucampo Pharma Europe, a subsidiary of Sucampo Pharmaceuticals Inc., announced that it has received marketing ... it has received marketing authorization for its Amitiza 24 microgram gel capsules in Switzerland. A2A SpA, ...


1 - 15 / 27      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS AMITIZA NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

send press release
EIN PRESSWIRE

Press Release Distribution Service
see all health press releases »see all press releases »

list your company
EINDIRECTORY

add listing
EINEVENTS

get free trial
EINNEWS PUBLICATIONS

FORMATS: RSS

EIN News Columnists

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Health Industry News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Science & Technology News

MORE ARTICLES >>>

Take This Poll

Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009)



 
FORMATS: RSS | EMAIL

Health Insurance News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Health Regulation News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Public Health News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Drugs News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Cancer News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Disease News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Nutrition News

MORE ARTICLES >>>
FORMATS: RSS | EMAIL

Aging News

MORE ARTICLES >>>

Healthcare Industry Today

Health & Healthcare News Sections
Drugs & Pharmaceuticals News Sections
Health News by Region
Health News by Country
Health News by U.S. State

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

ALL NEWS PUBLICATIONS

You are currently reading Healthcare Industry Today, an EIN News publication.

EIN News provides breaking news coverage on the following topics:

Regional / Politics
Barack Obama
Central Europe
China
EU Politics
Hillary Clinton
International Development
Military
Russia
US Politics
World News
Automotive
Automotive
Electric Cars
Hybrid Cars
Trucks		 Energy
Biofuels
Electric Power
Energy
Ethanol
Geothermal Power
Nuclear Power
Oil & Gas
Power Plants
Renewable Energy
Solar Energy
Wind Energy
Health / Pharmaceuticals
Brain Cancer
Breast Cancer
H1N1
Health
Lung Cancer
Mesothelioma
Pharmaceuticals
Prostate Cancer		 Business / Finance
Banking
Conferences
Employment
FOREX Trading
Finance
Gold
International Trade
Investing
Marketing
Real Estate
Science / Technology
Biotechnology
Environment
Global Warming
IT
Nanotechnology
Semiconductors
Software
Technology		 Culture / Society / Lifestyle
Books
Consumer
Human Rights
Media
Movies
Music
Religion
Travel
Company Daily Reports
Airbus
BP Energy
Boeing
Coca-Cola
ConocoPhillips
Exxon Mobil
Gazprom
Pepsi-Cola
Shell Energy
Starbucks		 Industry
Agriculture
Airlines
Chemicals
Cosmetics
Mining
Mobile Phone
Patents & Trademarks
Shipping & Logistics
Textiles
Tobacco
Waste Management
Food / Beverages
Beverages
Fast Food
Food Industry
Food Safety
Organic Food
Seafood

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.

EIN News © 1995 - 2009 IPD Group, Inc. All Rights Reserved. | User Agreement | Privacy Policy | Contact